mRNA Vaccines and Therapeutics

MRNA Vaccines and Therapeutics Market By Type (Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, mRNA Therapeutic for Other Diseases), By Mechanism Of Action (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, Others), By Application (Infectious Disease, Cancer, Other), Industry Analysis, Trends, and Forecast 2019 – 2025

Report ID: BMRC 974 | Number of pages: 205 | Publish Date: Sep 2019 | Category: Lifesciences and Healthcare
mRNA Vaccines and Therapeutics Market is valued at USD 3.39 Billion in 2018 and expected to reach USD 6.39 Billion By 2025 with the CAGR of 9.5% over the forecast period. Increase in licensing agreements with increased prevalence of chronic disorders is likely to grow the mRNA vaccines and therapeutics market.

Scope of mRNA Vaccines and Therapeutics Market Report:

mRNA (messenger RNA) is a genetic material which carries the genetic information from DNA to ribosome and where it specifies the sequence of amino acids for the protein synthesis. mRNA vaccines and therapeutics are prepared with the help of advanced technology and offers the most efficient and cost effective options with reduced side effects with increased immunogenicity. The demand for mRNA vaccines & therapeutics has increased due to the increase in various diseases such as cancer, infectious disease such as ebola virus, zika virus and many more. mRNA Vaccines and Therapeutics Market report is segmented on type, mechanism of action, application and by regional & country level. Based upon type, mRNA vaccines and therapeutics market is segmented into Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, and mRNA Therapeutic for Other Diseases. On the basis of mechanism of action, the market is segmented into Bioengineered Vaccine, Gene Therapy (Gene Silencing/Suppression), Gene Transcription (Protein Generation), Cell Therapy, Monoclonal Antibody, and Others. Based upon application, mRNA vaccines and therapeutics market is classified into Infectious Disease, Cancer, and Other. The regions covered in this mRNA Vaccines and Therapeutics market reports are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of mRNA Vaccines and Therapeutics market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for mRNA Vaccines and Therapeutics Market Reports– Some major key players for mRNA Vaccines and Therapeutics market are Moderna Therapeutics, Translate Bio, BioNTech, Argos Therapeutics, eTheRNA, Sangamo Therapeutics, In-Cell-Art, CureVac, Ethris, and Tiba Biotechnology among others Increase in licensing agreements with increased prevalence of chronic disorders is the key factor which helps mRNA Vaccines and Therapeutics Market to grow.- Over the period of time there has been tremendous increase in the prevalence of cronic disorders and infectious diseases on a large scale. Furthermore, constant increase in the various infections disease has increased the demand for effective and efficient vaccines and therapeutics for the treatment. There has been significant increase in the licensing agreement between manufacturers for the development of mRNA vaccine and therapeutics. Moreover, increase in approval of from various regulatory bodies such as FDA, CE and others are also expected to drive the growth of mRNA vaccines and therapeutic market. Increased adoption of mRNA vaccines and therapeutics and reduced manufacturing time has also promoted the market growth. The increase in research and development activities coupled with advanced technology is expected to create ample opportunities on a long run. However, high cost involved in the development of mRNA vaccine and therapeutic market is expected to hinder the growth of mRNA vaccines and therapeutics market in the near future. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global MRNA Vaccines and Therapeutics Market. bKey Benefits for MRNA Vaccines and Therapeutics Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape. mRNA Vaccines and Therapeutics Market Segmentation – By Type • Standardized Therapeutic Cancer mRNA Vaccines • Individualized Therapeutic Cancer mRNA Vaccines • Therapeutic Infectious Disease mRNA Vaccines • mRNA Therapeutic for Other Diseases By Mechanism Of Action • Bioengineered Vaccine • Gene Therapy (Gene Silencing/Suppression) • Gene Transcription (Protein Generation) • Cell Therapy • Monoclonal Antibody • Others By Application • Infectious Disease • Cancer • Other By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa North America is expected to dominate the mRNA Vaccines and Therapeutics Market.- North America is expected to account for the major market share over the forecast period owing to the presence of developed economies such as U.S., Canada, and others. Increase adoption of advanced vaccines and therapeutics due to the high disposable income and increased prevalence of chronic and infectious diseases are expected to drive the growth of mRNA vaccines and therapeutics market over the forecast period. Europe is expected to account the second largest market share owing to the increase in clinical trials, research and development activities coupled with advanced technology. Asia Pacific is expected to develop significantly and maintain its dominance over the forecast period due to the presence of developing economies such as India, China and others. Moreover, increase in infectious disease and increased adoption of advanced medicines and vaccines due to the developing healthcare facilities. Latin America, Middle East and Africa is expected to show substantial growth over the forecast period. MRNA Vaccines and Therapeutics Market Key Players: • Moderna Therapeutics • Translate Bio • BioNTech • Argos Therapeutics • eTheRNA • Sangamo Therapeutics • In-Cell-Art • CureVac • Ethris • Tiba Biotechnology • Others This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content

1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global MRNA Vaccines and Therapeutics Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global MRNA Vaccines and Therapeutics Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. MRNA Vaccines and Therapeutics Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global MRNA Vaccines and Therapeutics Market Overview: Quantitative Analysis
3.1. Global MRNA Vaccines and Therapeutics Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global MRNA Vaccines and Therapeutics Market Revenue Market Share (%), 2014- 2025
3.3. Global MRNA Vaccines and Therapeutics Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global MRNA Vaccines and Therapeutics Market Sales Market Share (%), 2014- 2025
4. Chapter – Global MRNA Vaccines and Therapeutics Market Analysis: By Type
5. Chapter – Global MRNA Vaccines and Therapeutics Market Analysis: By Mechanism Of Action
6. Chapter – Global MRNA Vaccines and Therapeutics Market Analysis: By Application
7. Chapter - Global MRNA Vaccines and Therapeutics Market Analysis: By Manufacturer 
7.1. Global MRNA Vaccines and Therapeutics Market Revenue (USD Million), by Manufacturer, 2014 - 2025
7.2. Global MRNA Vaccines and Therapeutics Market Share (%), by Manufacturer, 2018
7.3. Global MRNA Vaccines and Therapeutics Market Sales (Number of Units), by Manufacturer, 2014 - 2025
7.4. Global MRNA Vaccines and Therapeutics Market Share (%), by Manufacturer, 2018
7.5. Global MRNA Vaccines and Therapeutics Market Price (USD/Unit), by Manufacturer, 2014 - 2025
7.6. Global MRNA Vaccines and Therapeutics Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
7.7. Merger & Acquisition
7.8. Collaborations and Partnership
7.9. New Product Launch
8. Chapter –MRNA Vaccines and Therapeutics Market: Regional Analysis
8.1. North America
8.1.1. North America MRNA Vaccines and Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
8.1.2. North America MRNA Vaccines and Therapeutics Market Revenue (USD Million) By Country, 2014 – 2025.
8.1.3. North America MRNA Vaccines and Therapeutics Revenue Market Share (%) By Country, 2014 – 2025.
8.1.4. North America MRNA Vaccines and Therapeutics Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.5. North America MRNA Vaccines and Therapeutics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.6. North America MRNA Vaccines and Therapeutics Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
8.1.7. North America MRNA Vaccines and Therapeutics Market Sales (Number of Units) By Country, 2014 – 2025.
8.1.8. North America MRNA Vaccines and Therapeutics Sales Market Share (%) By Country, 2014 – 2025.
8.1.9. North America MRNA Vaccines and Therapeutics Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.10. North America MRNA Vaccines and Therapeutics Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter - Company Profiles
9.1. Moderna Therapeutics
9.1.1. Overview
9.1.2. Financials
9.1.3. Product portfolio
9.1.4. MRNA Vaccines and Therapeutics Market Revenue (USD Million) and Market Share (%), 2014 - 2018
9.1.5. MRNA Vaccines and Therapeutics Sales Market Share (%), 2014 - 2018
9.1.6. Business strategy
9.1.7. Recent developments
9.2. Translate Bio
9.3. BioNTech
9.4. Argos Therapeutics
9.5. eTheRNA
9.6. Sangamo Therapeutics
9.7. In-Cell-Art
9.8. CureVac
9.9. Ethris
9.10. Tiba Biotechnology
9.11. Others
10. Chapter – Market Research and Findings